BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 12354487)

  • 41. Hormone Replacement Therapy, Likely Neither Angel Nor Demon.
    Wachtel MS; Yang S; Dissanaike S; Margenthaler JA
    PLoS One; 2015; 10(9):e0138556. PubMed ID: 26384022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Elements of informed consent for hormone replacement therapy in patients with diagnosed breast cancer.
    Chlebowski RT; McTiernan A
    J Clin Oncol; 1999 Jan; 17(1):130-42. PubMed ID: 10458226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hormone replacement therapy and breast cancer.
    Howell A; Evans GD
    Recent Results Cancer Res; 2011; 188():115-24. PubMed ID: 21253794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases.
    Vinogradova Y; Coupland C; Hippisley-Cox J
    BMJ; 2020 Oct; 371():m3873. PubMed ID: 33115755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Do women taking hormone replacement therapy (HRT) have a higher incidence of breast cancer than women who do not?
    Fleming RM
    Integr Cancer Ther; 2003 Sep; 2(3):235-7. PubMed ID: 15035886
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hormone replacement therapy and menopause: a review of randomized, double-blind, placebo-controlled trials.
    Chang C; Lin CH
    Kaohsiung J Med Sci; 2003 Jun; 19(6):257-70. PubMed ID: 12873034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The oncologic impact of hormone replacement therapy in premenopausal breast cancer survivors: A systematic review.
    Wang Y; Lewin N; Qaoud Y; Rajaee AN; Scheer AS
    Breast; 2018 Aug; 40():123-130. PubMed ID: 29763858
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The risks and benefits of hormonal replacement therapy in healthy women and in breast cancer survivors.
    Welnicka-Jaskiewicz M; Jassem J
    Cancer Treat Rev; 2003 Oct; 29(5):355-61. PubMed ID: 12972354
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ovarian cancer and hormone replacement therapy in the Million Women Study.
    Beral V; ; Bull D; Green J; Reeves G
    Lancet; 2007 May; 369(9574):1703-10. PubMed ID: 17512855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.
    Collaborative Group on Hormonal Factors in Breast Cancer
    Lancet; 2019 Sep; 394(10204):1159-1168. PubMed ID: 31474332
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The adverse effects of hormone replacement therapy.
    Tavani A; La Vecchia C
    Drugs Aging; 1999 May; 14(5):347-57. PubMed ID: 10408735
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bias in Observational Studies of the Association between Menopausal Hormone Therapy and Breast Cancer.
    Zahl PH; Mæhlen J
    PLoS One; 2015; 10(5):e0124076. PubMed ID: 25938446
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Menopause, hormone replacement therapy and cancer.
    La Vecchia C; Brinton LA; McTiernan A
    Maturitas; 2001 Aug; 39(2):97-115. PubMed ID: 11514109
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Women's international study of long-duration oestrogen after menopause (WISDOM): a randomised controlled trial.
    Vickers MR; Martin J; Meade TW;
    BMC Womens Health; 2007 Feb; 7():2. PubMed ID: 17324282
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The demise of HRT? The long-term safety of hormone replacement therapy.
    Fenton A
    Expert Opin Drug Saf; 2003 Jul; 2(4):341-5. PubMed ID: 12904091
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hormone replacement therapy regimens and breast cancer risk(1).
    Weiss LK; Burkman RT; Cushing-Haugen KL; Voigt LF; Simon MS; Daling JR; Norman SA; Bernstein L; Ursin G; Marchbanks PA; Strom BL; Berlin JA; Weber AL; Doody DR; Wingo PA; McDonald JA; Malone KE; Folger SG; Spirtas R
    Obstet Gynecol; 2002 Dec; 100(6):1148-58. PubMed ID: 12468157
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risks and benefits of long-term hormone replacement therapy.
    Biscup P
    Am J Health Syst Pharm; 2003 Jul; 60(14):1419-25. PubMed ID: 12892026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does hormone replacement therapy (HRT) cause breast cancer? An application of causal principles to three studies.
    Shapiro S; Farmer RD; Stevenson JC; Burger HG; Mueck AO; Gompel A
    J Fam Plann Reprod Health Care; 2013 Apr; 39(2):80-8. PubMed ID: 23493592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Puzzle of hormone replacement therapy and prospect of the role of traditional Chinese medicine in treating postmenopausal syndrome].
    Chen MD; Yang Y
    Zhong Xi Yi Jie He Xue Bao; 2003 May; 1(1):9-11. PubMed ID: 15339602
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hormone replacement therapy: review, update, and remaining questions after the Women's Health Initiative Study.
    Stevenson JC
    Curr Osteoporos Rep; 2004 Mar; 2(1):12-6. PubMed ID: 16036077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.